These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 108388)

  • 41. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Aldouri MA; Hoffbrand AV; Barr J; Wonke B; Kourouclaris T; Sheppard L
    Br Med J (Clin Res Ed); 1987 Dec; 295(6612):1509-12. PubMed ID: 3122880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The development of new iron-chelating drugs.
    Grady RW; Graziano JH; Akers HA; Cerami A
    J Pharmacol Exp Ther; 1976 Feb; 196(2):478-85. PubMed ID: 1255491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The development of new iron-chelating drugs. II.
    Grady RW; Graziano JH; White GP; Jacobs A; Cerami A
    J Pharmacol Exp Ther; 1978 Jun; 205(3):575-65. PubMed ID: 660531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coordination chemistry of microbial iron transport compounds: rhodotorulic acid and iron uptake in Rhodotorula pilimanae.
    Carrano CJ; Raymond KN
    J Bacteriol; 1978 Oct; 136(1):69-74. PubMed ID: 30750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The selection and evaluation of new chelating agents for the treatment of iron overload.
    Pitt CG; Gupta G; Estes WE; Rosenkrantz H; Metterville JJ; Crumbliss AL; Palmer RA; Nordquest KW; Hardy KA; Whitcomb DR; Byers BR; Arceneaux JE; Gaines CG; Sciortino CV
    J Pharmacol Exp Ther; 1979 Jan; 208(1):12-8. PubMed ID: 759605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preclinical and clinical development of deferitrin, a novel, orally available iron chelator.
    Donovan JM; Plone M; Dagher R; Bree M; Marquis J
    Ann N Y Acad Sci; 2005; 1054():492-4. PubMed ID: 16339704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Current possibilities in the therapy of iron overload].
    Cermák J
    Vnitr Lek; 1994 Sep; 40(9):605-8. PubMed ID: 7975366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rhodotorulic acid--investigation of its potential as an iron-chelating drug.
    Grady RW; Peterson CM; Jones RL; Graziano JH; Bhargava KK; Berdoukas VA; Kokkini G; Loukopoulos D; Cerami A
    J Pharmacol Exp Ther; 1979 Jun; 209(3):342-8. PubMed ID: 108388
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.